换一批
换一批Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility gene.
作者：
Ed,Dicks [1]
;
Honglin,Song [1]
;
Susan J,Ramus [2]
;
Elke Van,Oudenhove [3]
;
Jonathan P,Tyrer [1]
;
Maria P,Intermaggio [4]
;
Siddhartha,Kar [1]
;
Patricia,Harrington [1]
;
David D,Bowtell [5]
;
Aocs Study,Group [6]
;
Mine S,Cicek [7]
;
Julie M,Cunningham [7]
;
Brooke L,Fridley [8]
;
Jennifer,Alsop [1]
;
Mercedes,Jimenez-Linan [9]
;
Anna,Piskorz [3]
;
Teodora,Goranova [3]
;
Emma,Kent [10]
;
Nadeem,Siddiqui [11]
;
James,Paul [12]
;
Robin,Crawford [13]
;
Samantha,Poblete [14]
;
Shashi,Lele [14]
;
Lara,Sucheston-Campbell [15]
;
Kirsten B,Moysich [15]
;
Weiva,Sieh [16]
;
Valerie,McGuire [16]
;
Jenny,Lester [17]
;
Kunle,Odunsi [14]
;
Alice S,Whittemore [16]
;
Natalia,Bogdanova [18]
;
Matthias,Dürst [19]
;
Peter,Hillemanns [20]
;
Beth Y,Karlan [17]
;
Aleksandra,Gentry-Maharaj [21]
;
Usha,Menon [21]
;
Marc,Tischkowitz [22]
;
Douglas,Levine [23]
;
James D,Brenton [3]
;
Thilo,Dörk [24]
;
Ellen L,Goode [7]
;
Simon A,Gayther [25]
;
D P Paul,Pharoah [26]
作者单位：
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
[1]
School of Women's and Children's Health, University of New South Wales, Sydney, Australia.;The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia.
[2]
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
[3]
School of Women's and Children's Health, University of New South Wales, Sydney, Australia.
[4]
Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.;Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia.;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.;Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
[5]
Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.;Westmead Millennium Institute, Westmead Hospital, Sydney, Australia.;The QIMR Berghofer Medical Research Institute, Brisbane, Australia.
[6]
Mayo Clinic, Rochester, Minnesota, USA.
[7]
Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas, USA.
[8]
Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK.
[9]
MRC Clinical Trials Unit, University College London, London, UK.
[10]
Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland.
[11]
Dept Gynaecol Oncology, Glasgow Royal Infirmary, Glasgow, Scotland.
[12]
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
[13]
Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
[14]
Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
[15]
Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
[16]
Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[17]
Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.;Radiation Oncology Research Unit, Hannover Medical School, Hannover, Germany.;Mother and Child Hospital, Minsk, Belarus.
[18]
Department of Obstetrics and Gynaecology, Friedrich-Schiller University, Jena, Germany.
[19]
Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
[20]
Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, London, UK.
[21]
Department of Medical Genetic, University of Cambridge, Cambridge, UK.
[22]
Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
[23]
Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
[24]
Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.;Center for Bioinformatics and Functional Genomics, Department Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[25]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.;Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
[26]
DOI
10.18632/oncotarget.15871
PMID
28881617
发布时间
2024-09-20
- 浏览10
Oncotarget
Oncotarget
50930-50940页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
